While industry has often complained devices are able to get to market sooner in Europe than the US because of the CE mark system, Jeff Shuren, director of FDA's device center thinks they have struck the right regulatory balance between public safety and an environment to allow innovation.
Speaking before stakeholders at this year's Transcatheter Cardiovascular Therapeutics conference in San Francisco, Shuren acknowledged medical devices are often available...